Literature DB >> 27408333

Effects of the -791(C→T) mutation in the promoter for tumor necrosis factor alpha on gene expression and resistance of Large White pigs to enterotoxigenic Escherichia coli F18.

Ying Liu1, Chaohui Dai1, Li Sun1, Guoqiang Zhu1, Shenglong Wu1, Wenbin Bao1.   

Abstract

Tumor necrosis factor alpha (TNF-α) plays an important role in the immune system. In this study, TNF-α expression was analyzed in 11 tissues of 8 piglets resistant to enterotoxigenic Escherichia coli (ETEC) F18 and 8 ETEC F18-susceptible piglets from the Large White breed. The expression levels of TNF-α were high in immune organs (spleen, lung, thymus, and lymph nodes). The levels were higher in ETEC F18-resistant piglets than in ETEC F18-susceptible piglets, with significant differences in spleen, kidney, thymus, lymph node, and duodenum (P < 0.05). The mutation TNF-α -791(C→T) and 3 genotypes (CC, CT, and TT) were identified. The TNF-α expression levels in the spleen, kidney, lymph nodes, and duodenum were significantly higher in the TT pigs than in the CC pigs (P < 0.05). Thus, TNF-α -791(C→T) has significant effects on mRNA expression and may regulate ETEC F18 resistance of weaning piglets. Therefore, the -791(C→T) mutation of the TNF-α gene could be considered an important potential genetic marker of ETEC F18 resistance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27408333      PMCID: PMC4924554     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  21 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Waste management - cytokines, growth factors and cachexia.

Authors:  Amarjit Saini; Nasser Al-Shanti; Al-Shanti Nasser; Claire E H Stewart
Journal:  Cytokine Growth Factor Rev       Date:  2006-11-22       Impact factor: 7.638

3.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

Review 4.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

5.  Genetic variation in exon 10 of the BPI gene is associated with Escherichia coli F18 susceptibility in Sutai piglets.

Authors:  Lu Liu; Jing Wang; Qiaohui Zhao; Chen Zi; Zhengchang Wu; Xianmin Su; Yongjiu Huo; Guoqiang Zhu; Shenglong Wu; Wenbin Bao
Journal:  Gene       Date:  2013-04-04       Impact factor: 3.688

6.  TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients.

Authors:  A Lanas; M A García-González; S Santolaria; J B Crusius; M T Serrano; R Benito; A S Peña
Journal:  Genes Immun       Date:  2001-12       Impact factor: 2.676

Review 7.  The mucosal immune system: from specialized immune defense to inflammation and allergy.

Authors:  H Kiyono; M N Kweon; T Hiroi; I Takahashi
Journal:  Acta Odontol Scand       Date:  2001-06       Impact factor: 2.331

8.  Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection.

Authors:  T Höhler; A Kruger; G Gerken; P M Schneider; K H Meyer zum Büschenfelde; C Rittner
Journal:  J Med Virol       Date:  1998-03       Impact factor: 2.327

9.  Microarray analysis of differential gene expression in sensitive and resistant pig to Escherichia coli F18.

Authors:  W B Bao; L Ye; Z Y Pan; J Zhu; Z D Du; G Q Zhu; X G Huang; S L Wu
Journal:  Anim Genet       Date:  2011-11-07       Impact factor: 3.169

10.  Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6.

Authors:  H Schmitz; M Fromm; C J Bentzel; P Scholz; K Detjen; J Mankertz; H Bode; H J Epple; E O Riecken; J D Schulzke
Journal:  J Cell Sci       Date:  1999-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.